Literature DB >> 26475695

Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache.

Massimo Leone1, Alberto Proietti Cecchini2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26475695      PMCID: PMC4731683          DOI: 10.1212/WNL.0000000000002117

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Cardiorespiratory distress after sumatriptan given by injection.

Authors:  T Curtin; A P Brooks; J A Roberts
Journal:  BMJ       Date:  1992-09-19

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  Treatment of acute cluster headache with sumatriptan.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study.

Authors:  H Göbel; V Lindner; A Heinze; M Ribbat; G Deuschl
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

Review 5.  Tolerability of sumatriptan: clinical trials and post-marketing experience.

Authors:  K M Welch; N T Mathew; P Stone; W Rosamond; J Saiers; D Gutterman
Journal:  Cephalalgia       Date:  2000-10       Impact factor: 6.292

6.  Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group.

Authors:  K Ekbom; A Krabbe; G Micieli; A Prusinski; J A Cole; A J Pilgrim; D Noronha; G ] Micelli G [corrected to Micieli
Journal:  Cephalalgia       Date:  1995-06       Impact factor: 6.292

7.  Cardiac arrest following use of sumatriptan.

Authors:  K M Kelly
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

  7 in total
  1 in total

Review 1.  Pharmacotherapy for Cluster Headache.

Authors:  Roemer B Brandt; Patty G G Doesborg; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.